DigestRedComo funciona
Red
/
Empresas
Re
No verificado

Revelation Biosciences, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

23 Comunicados de prensa

Ver todos los comunicados de prensa
08/08/2025
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Mercado de valores
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
24/07/2025
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Mercado laboral
Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
16/07/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
01/07/2025
Biotecnología
VIH, SIDA y enfermedades autoinmunes
Salud
Farmacéutica
Medicina - Varios
Finanzas
Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
29/05/2025
Biotecnología
VIH, SIDA y enfermedades autoinmunes
Salud
Farmacéutica
Medicina - Varios
Mercado de valores
Finanzas
Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
29/05/2025
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Finanzas
Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
23/05/2025
Mercado laboral
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
08/05/2025
Mercado de valores
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
29/04/2025
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0
17/03/2025
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
Fuente
Revelation Biosciences, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0